|
About SierraNeuro:
Management Team, Board of Directors and Scientific Advisors
|
SierraNeuro Technology:
Off-patent generic compounds are the targets of Sierra's reformulation effort. There is currently no pharmaceutical company or pump manufacturer with an approach focused on direct delivery of neurological or psychiatric drugs to the brain.
|
SierraNeuro Clinical Trials:
REPLACE THIS TEXT WITH A BRIEF DESCRIPTION OF YOUR WEBSITE.
|
|
|
Careers at SierraNeuro:
REPLACE THIS TEXT WITH A BRIEF DESCRIPTION OF YOUR WEBSITE.
|
SierraNeuro News Room:
REPLACE THIS TEXT WITH A BRIEF DESCRIPTION OF YOUR WEBSITE.
|
Contact SierraNeuro:
Please fill out the form below and we will contact you shortly...
|
SierraNeuro Board of Directors:
REPLACE THIS TEXT WITH A BRIEF DESCRIPTION OF YOUR WEBSITE.
|
|
|
Privacy Policy:
This Privacy Policy describes Sierras use of Personal Information and Anonymous Information that we collect when you use our Sierra Services. This Privacy Policy does not apply to the use of your Personal Information by third parties that Sierra does not own or control, or to individuals that we do not control or manage.
|
Terms of Use:
BY ACCESSING THE WEBSITE, YOU AGREE TO BE BOUND BY THE TERMS OF USE. IF YOU DO NOT WISH TO BE BOUND BY THESE TERMS OF USE, YOU MAY NOT ACCESS OR USE THIS WEBSITE.
|
SierraNeuro:
biopharmaceutical company focused on the development and commercialization of small molecule therapeutic products for medically refractory patients with CNS disease.
|
|
|